Korro to present at the td cowen 45th annual health care conference

Cambridge, mass., feb. 26, 2025 (globe newswire) -- korro bio, inc. (korro) (nasdaq: krro), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing rna for both rare and highly prevalent diseases, today announced that ram aiyar, ph.d., chief executive officer and president, will present at the td cowen 45th annual health care conference on tuesday, march 4, 2025, at 11:50 a.m. et at the boston marriott copley place. todd chappell, chief operating officer, will also participate in 1x1 investor meetings at the conference.
COWN Ratings Summary
COWN Quant Ranking